Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Dopamine D5 receptor (DRD5) is a subtype of dopamine receptor belonging to the D1-like family. It is a G-protein coupled receptor that activates adenylyl cyclase, leading to increased cAMP production. DRD5 plays a role in regulating attention, mood, memory, learning, movement, and cognitive processes, particularly working memory. It is a potential therapeutic target for neuropsychiatric disorders and chronic pain, although the development of selective ligands remains a challenge.
Activation leads to stimulation of adenylyl cyclase → increased cAMP → downstream signaling cascades affecting neuronal excitability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine D5 Receptor (DRD5).